Home › Brain Tumors › Michigan › Grand Rapids
Brain Tumors clinical trials in Grand Rapids, MI
4 studies for Brain Tumors are looking for participants at sites in and around Grand Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RecruitingPhase 3
- Spectrum Health at Butterworth Campus, Grand Rapids
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RecruitingPhase 1/2
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecruitingPhase 2
- Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids
- Spectrum Health at Butterworth Campus, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RecruitingPhase 1
- START - Midwest Cancer Research Center, Grand Rapids
About Brain Tumors
A brain tumor is a growth of abnormal cells in the brain tissue. Learn the types of tumors, symptoms, how they are diagnosed and treatment options.
More about Brain Tumors on MedlinePlus
Brain Tumors trials in other cities
- Houston, TX37 studies
- Boston, MA29 studies
- New York City, NY25 studies
- Washington, DC21 studies
- Los Angeles, CA17 studies
- Durham, NC15 studies
- Miami, FL14 studies
- Chicago, IL12 studies
- Rochester, MN12 studies
- St. Louis, MO12 studies
- Cleveland, OH11 studies
- Columbus, OH11 studies
Other studies in Grand Rapids
- Non-Small Cell Lung Cancer46 studies
- Colorectal Cancer40 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Ovarian Cancer25 studies
- Metastatic Cancer21 studies
- Prostate Cancer21 studies
- Stomach Cancer20 studies
- Pancreatic Cancer19 studies
- Endometrial Cancer18 studies
- Head and Neck Squamous Cell Carcinoma17 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.